Abstract. The present study aimed to reduce the expression of interleukin-1 receptor-associated kinase 1 (IRAK-1) in dendritic cells (DCs) by RNA interference (RNAi). Subsequently, its effects on the expression of costimulatory surface molecules, the release of inflammatory cytokines, and the proliferation of T cells during the activation process of DCs, were determined. RNAi was used to silence IRAK-1 gene expression in DCs, followed by lipopolysaccharide stimulation. Flow cytometry was then used to detect the expression levels of DC surface molecules, including cluster of differentiation (CD)86, major histocompatibility complex class II and CD40. Quantitative polymerase chain reaction was conducted to detect the mRNA expression levels of Toll-like receptor 4, IRAK-4, IRAK-1 and nuclear factor-κB (NF-κB) in DCs. In addition, ELISA was used to detect the release of the following inflammatory cytokines: Interleukin (IL)-10, IL-12 and tumor necrosis factor-α (TNF-α). The MTS assay was used to determine the effects of IRAK-1 RNAi on T-cell proliferation. Knockdown of IRAK-1 gene expression in DCs significantly reduced the expression levels of costimulatory surface molecules and intracellular NF-κB, decreased release of the proinflammatory cytokines IL-12 and TNF-α, increased release of the anti-inflammatory cytokine IL-10, and significantly reduced the proliferation of T cells. These results suggested that suppression of IRAK-1 gene expression may inhibit the differentiation and maturation of DCs via the downregulation of DC surface molecules, inhibition of intracellular signal transduction pathways, regulation of inflammatory cytokine release, and by reducing its promoting effects on T-cell proliferation.
Introduction
Natural immunity is the primary line of defense in the resistance of the body against the invasion of foreign pathogens. Induction of the immune response is dependent on recognition and binding of pattern recognition receptors (PRRs), which are found on the surface of natural immune cells, towards the pathogen-associated molecular patterns (PAMPs), thus resulting in activation of signaling pathways and the release of proinflammatory cytokines (1) . Toll-like receptors (TLRs) are the most important innate PRRs that mediate the generation of proinflammatory cytokines and initiate the immune response. At present, 14 types of TLR have been identified in mammals, which serve important roles in recognizing foreign antigens, promoting the innate immune response, and promoting activated signaling transduction in cells (2, 3) .
Although the number of dendritic cells (DCs) is <1% of mononuclear cells in peripheral blood, their surface is rich with antigen-presenting molecules [major histocompatibility complex class I(MHC I) and MHC II], costimulatory molecules [cluster of differentiation (CD)80/B7-1, CD86/B7-2, CD40 and CD44] and adhesion molecules [intercellular adhesion molecule (ICAM)-1, ICAM-2, ICAM-3, lymphocyte function-associated antigen (LFA)-1, LFA-3]. Therefore, DCs are considered the strongest professional antigen-presenting cells (APCs) (4) . DCs express various PRRs (5), including TLRs, nucleotide-binding oligomerization domain-like receptors, retinoic acid-inducible gene I-like receptors and C-type lectins; these PRRS are able to initiate the transduction of cell signaling and the expression of related genes.
It has been reported that in response to lipopolysaccharide (LPS), TLRs promote interleukin-1 (IL-1)-induced signal transduction in order to mediate activation of other antigen-induced immune cells; this process has been confirmed by TLR2-and TLR4-mediated cellular responses (6) . IL-1 receptor-associated kinases (IRAKs) are factors in the TLR/IL-1 receptor (IL-1R) signaling pathway, which has an important role in regulating Effects of interleukin-1 receptor-associated kinase 1 RNA interference in dendritic cells on inflammatory cytokine release and T-cell proliferation (9) . After binding of LPS to TLR4, regulation of the transcription of various genes occurs via nuclear factor-κΒ (NF-κΒ) and mitogen-activated protein kinase (MAPK) pathways, thus promoting the maturation of DCs. As a key factor in the TLR/IL-1R signaling pathway, IRAK-1 has an important role in the differentiation and maturation of DCs.
In the present study, RNA interference (RNAi) was performed to silence the gene expression of IRAK-1 in DCs. The present study aimed to determine the underlying mechanisms of IRAK-1 towards the differentiation and maturation of DCs, as well as to investigate its effects on DC physiological functions, including antigen presentation and the promotion of lymphocyte activation.
Materials and methods
Extraction and culture of DCs. Female C57 BL/6 mice (age, 4 weeks; weight, 13-15 g; specific-pathogen-free level; Experimental Animal Center of Chinese Medical University, Shenyang, China) were selected for use in the present study. The mice were housed with a 12 h light/dark cycle, at 22±2˚C, and free access to food and water. Following intraperitoneal injection of 4% chloraldurate (0.01 ml/g body weight), the mice were sacrificed by cervical spine dislocation in order to obtain the femurs, from which the bone marrow cells were collected and placed into 10% fetal bovine serum (FBS)-containing 1640 medium (Sigma-Aldrich; Merck Millipore, Darmstadt, Germany). The cells were cultured at 37˚C in an atmosphere containing 5% CO 2 for 24 h. Subsequently, the supernatant was discarded, 10 µg/ml IL-4, 10 µg/ml granulocyte-macrophage colony-stimulating factor (GSM-CF) and 10% FBS-containing 1640 medium were added and the cells were cultured for a further 6 days; half of the medium was changed every 24 h. The supernatant was then discarded and the cells were resuspended in 10% FBS-containing 1640 medium supplemented with IL-4 and GSM-CF. Subsequently, the cells were counted, re-seeded into 6-well plates (1x10 6 /ml) and cultured at 37˚C in an atmosphere containing 5% CO 2 for further experimentation. The study was approved by the ethics committee of Shengjing Hospital of China Medical University (Shenyang, China). 
Reverse transcription-quantitative polymerase reaction (RT-qPCR).
After 24 h LPS stimulation, the total RNA was extracted from the cells using RNAiso Plus kit (Takara Biotechnology Co., Ltd., Dalian, China) according to the manufacturer's instructions. The reverse transcription reaction was performed using PrimeScript™ RT kits (Takara Biotechnology Co., Ltd.) according to the manufacturer's instructions. The RT reaction was performed at 37˚C for 15 min, followed by 85˚C for 5 sec, and the reaction system (20 µl for each sample) was as follows: 4 µl PrimeScript Buffer (5X); 1 µl PrimeScript RT Enzyme Mix I; 1 µl oligo dt Primer (50 µmol/l); 1 µl random hexamers (100 µmol/l); and 13 µl total RNA. The PCR system (15 µl for each sample) was as follows: 7.5 µl Premix Ex Taq (2X); 0.25 µl forward primer (10 µmol/l); 0.25 µl reverse primer (10 µmol/l); 3 µl cDNA (5 ng/µl); and 4 µl dH 2 O. Primers were designed and synthesized by Takara Biotechnology Co., Ltd. (Dalian, China) with β-actin used as the internal reference gene (Table I) Flow cytometry. Following 24 h LPS stimulation, DCs in the three groups were collected, washed twice with flow cytometry buffer and adjusted to a cell concentration of 1x10 6 /l. The cells were then incubated with allophycocyanin-CD86 (cat. no. 11-0862), phycoerythrin (PE)-MHC II (cat. no. 11-0367) and PE-CD40 (cat. no. 12-0401) antibodies (eBioscience, Inc.), at final concentrations of 5 µg/ml, in the dark at 4˚C for 30 min. The surface-specific markers of DCs, namely CD86, MHC II and CD40, were then detected using flow cytometry.
ELISA assay. Following 24 h LPS stimulation, ELISA kits (eBioscience, Inc.) were used to detect IL-10 (cat. no. 88-7314), IL-12 P70 (cat. no. 88-7121) and tumor necrosis factor-α (TNF-α; cat. no. 88-7324) in the cell supernatant.
Extraction of T lymphocytes.
Female C57 BL/6 mice (age, 4 weeks) were sacrificed and spleens were collected. The spleen samples were placed in PBS and cut into small pieces using scissors. A 200-mesh sieve was then used to gently grind the small spleen sections into a single cell suspension, which was cleared using erythrocyte lysate for 5 min. The suspension was then centrifuged at 300 x g for 6 min to discard the supernatant, the cells were resuspended in PBS, and were placed in 10% FBS-containing 1640 medium for further use.
S o r t i ng of n a i ve T l y m p h o c y t e s. T h e M o u s e CD4
+ /CD62L + /CD44 low Naive Column sorting kit (R&D Systems, Inc., Minneapolis, MN, USA) was used to sort the spleen single cell suspensions, according to the manufacturer's protocol. Naive T cells that exhibited the expression profile CD4 + CD62L + CD44 -were obtained and cultured in 10% FBS-containing 1640 medium.
Mixed cell reaction. Following 24 h LPS stimulation, the cells of the three groups were co-cultured with CD4 + CD62L + CD44 -naive T cells; the ratios of DCs to naive T cells used were 1:1, 1:10, 1:50 and 1:100. After 48 h co-culture, the MTS assay kit (Promega Corporation, Madison, WI, China) was used to detect the proliferation of naive T cells according to the manufacturer's protocol. The absorbance at detected at 490 nm.
Statistical analysis. All experiments were repeated three times. The data are presented as the mean ± standard error of the mean, and were analyzed using SPSS 16.0 statistical software (SPSS Inc., Chicago, IL, USA). Intergroup comparisons were made using one-way analysis of variance and least significant difference tests. Prism version 6.01 (GraphPad Software, Inc., La Jolla, CA, USA) was used to generate the figures. P<0.05 was considered to indicate a statistically significant difference.
Results

Identification of BMSCs-originated DCs.
After BMSCs were cultured in medium containing GSM-CF and IL-4, flow cytometry revealed that the ratio of CD11c + cells was 79.8% (Fig. 1) . Cells obtained from the preliminary culture were then further sorted using magnetic beads, and flow cytometry revealed that the ratio of CD11c + cells was 95.7% (Fig. 2) .
qPCR. qPCR was used to detect mRNA expression levels ( Fig. 3) . Following LPS stimulation, the mRNA expression levels of IRAK-1 in the LPS + IRAK-1 siRNA group were significantly reduced (P<0.05; Fig. 3A ). In addition, the mRNA expression levels of NF-κB p65 were decreased in the LPS + IRAK-1 siRNA group (P<0.05; Fig. 3C ). There were no significant differences in the mRNA expression levels of IRAK-1 and NF-κB p65 between the LPS + mock and LPS + scrambled siRNA groups (Fig. 3A and C) , thus indicating that IRAK-1 RNAi could reduce its expression in DCs, thus reducing the expression of NF-κB p65. Furthermore, the mRNA expression levels of TLR4 and IRAK-4 were not significantly different among the three groups (P>0.05; Fig. 3B and D) . These results indicate that interfering with the gene expression of IRAK-1 has no significant effects on the mRNA expression levels of the upstream molecules TLR4 and IRAK-4.
Flow cytometry. Following LPS stimulation, flow cytometry was performed to detect MHC II, CD40 and CD86 expression among the three groups. The results demonstrated that the expression levels of MHC II, CD40 and CD86 in the LPS + mock and LPS + scrambled siRNA groups were significantly higher compared with in the LPS + IRAK-1 siRNA group (P<0.05). However, there was no significant difference between the LPS + mock and LPS + scrambled siRNA groups (Fig. 4) . These results indicate that following knockdown of IRAK-1 expression with RNAi, LPS stimulation was able to reduce the expression levels of CD80, MHC II and CD40 in DCs.
ELISA. ELISA kits were used to determine the release of cytokines by DCs (Fig. 5) . The results demonstrated that following RNAi-induced knockdown of IRAK-1 gene expression, LPS stimulation was able to significantly reduce the expression levels of the inflammatory cytokines IL-12 and TNF-α ( Fig. 5B and C) , and promote the expression of the anti-inflammatory cytokine IL-10 ( Fig. 5A ). There was no difference in the expression levels of IL-12, TNF-α and IL-10 between the LPS + mock and LPS + scrambled siRNA groups; however, when compared with the LPS + IRAK-1 siRNA group, the expression levels of IL-12 and TNF-α were significantly increased, whereas IL-10 expression was significantly reduced. Mixed cell reaction. DCs and spleen-originated naive T cells were co-cultured, and cell proliferation was subsequently detected using the MTS assay. The results demonstrated that DCs could significantly promote the proliferation of naive T cells, which was also associated with the ratio of cell mixtures; the higher the proportion of DCs to naive T cells, the more marked the promoting effects of DCs towards their proliferation (Fig. 6) . However, when IRAK-1 gene expression was suppressed by RNAi, the promoting effects of DCs towards the proliferation of naive T cells were significantly reduced.
Discussion
Natural immunity is the primary line of defense in the resistance of the body against the invasion of foreign pathogens. Within the IRAKs family, IRAK-1 serves key roles in the IL-1 signaling pathway, and was the first identified IL-1 receptor kinase. Human and murine IRAK-1 were initially cloned in 1996, and Thomas et al demonstrated that the IRAK-1 gene was located at Xq29.52-q 29.7 in rats, and at Xq2810 in humans (11) . The molecular weight of IRAK-1 is ~80 kDa. Following activation it can be expressed as a ~100 kDa modified form, which via various modifications, including phosphorylation, ubiquitination, acetylation and polyubiquitination, exerts different functions, including interferon regulatory factor (IRF)5/IRF7, MAPK, and NF-κB and signal transducer and activator of transcription signaling pathway activation (12) (13) (14) .
It has been reported that in IRAK-1-deficient macrophages, the expression levels of TNF-α are reduced when TLR2 or TLR4 are activated; this type of TLR-associated damage could weaken the response against the fatal effects of sepsis caused by LPS or gram-negative bacilli (15) . Deng et al (16) reported that IRAK-1 -/-mice are susceptible to a high dose of S. aureus compared with wild-type controls. By contrast to the high mortality and extensive weight loss observed in IL-1R-deficient mice in response to 1x10 6 EAE is a T cell-mediated autoimmune disease in mice. The application of myelin protein and complete Freund's adjuvant is able to sensitize mice, resulting in the production of clinical features similar to those observed in human multiple sclerosis. A previous study reported that TLR4 functional defects could weaken activation of T helper (Th)17 and Th1 cells in an EAE model, significantly reducing the symptoms of EAE (19) , thus suggesting that TLR4 has a key mediating role in the occurrence of EAE. Furthermore, Deng et al (16) demonstrated in animal studies that IRAK-1-deficient mice were resistant to EAE so that little or no inflammatory response could be detected in the central nervous system of the mice, and the functions of Th1 cells were reduced in such mice. It could be hypothesized that the possible reason underlying EAE resistance was due to the suppression of TLR activation during APC-activated IL-1R signaling, which relies on IRAK-1. Other studies have also confirmed that IL-1R-and IL-18-deficient mice appear resistant to the EAE model (20, 21) . Therefore, it may be speculated that IRAK-1 is associated with EAE; however, the specific mechanisms underlying the effects of IRAK-1 on the occurrence and development of EAE require further investigation. A previous study reported that the TLR pathway was able to activate the downstream transcription factor NF-κB, thus inducing the expression of various proinflammatory genes (22) . IRAK-1 is located downstream of TLR2 in this signaling pathway; therefore, it may serve major roles in signaling transduction from TLR to NF-κB activation. In the inflammatory responses of various autoimmune diseases, Th17 and Th1 cells serve promoting roles, whereas regulatory T cells (Treg cells) inhibit this type of regulation; therefore, the responses of Th17 and Th1 cells may be closely associated with the occurrence and development of diseases. IRAK-1 has been confirmed to have key roles in promoting T-cell differentiation towards Th1 and Th17, which may promote the differentiation of Th17 cells and inhibit the generation of Treg cells (23) . Therefore, IRAK-1 inhibitors may be considered potential clinical therapeutic tools for the treatment of autoimmune diseases.
The development process of DCs can be divided into two stages: Immature DCs and mature DCs, which exert various functions. Under normal circumstances, the majority of DCs in vivo, which are predominantly contained inside non-lymphoid tissues, are in an immature state. Following ingestion of antigens or stimulation by certain factors (such as LPS, IL-1β and TNF-α), they may differentiate and become mature. Mature DCs express high levels of MHC molecules, costimulatory molecules and adhesion molecules, integrins (beta-1, beta-2), and characteristic markers (CD1a, CD11c, CD83); secrete cytokines, such as IL-12, IL-2l, IL-26, IL-28, TNF-α and IFN-α; and stimulate mixed lymphocyte reaction to enhance its abilities. DCs are associated with various autoimmune diseases, and have important roles in the occurrence and development of autoimmune diseases, including multiple sclerosis and its animal model EAE (24) . A previous study demonstrated that following pretreatment with LPS and myelin basic protein, the injection of DCs into mice may induce generation of an EAE model (25) . Furthermore, a previous study demonstrated that LPS could promote the differentiation of DCs; following the addition of LPS into the DCs culture system, the most typical form of mature DCs appeared after 6 days, the expression levels of mature surface markers CD80 and CD86 were increased, the secretion of IL-6 and IL-12 were significantly increased, and its roles regarding stimulation of the activation and proliferation of allogeneic T cells were enhanced (8) . Another study reported that LPS could promote the maturation of DCs predominantly through the TLRs signaling pathway; after binding with TLR4, LPS may adjust the transcription of various genes via NF-κΒ and MAPK pathways, thus promoting DC maturation (9) . As a key factor in the TLR/IL-1R signaling pathway, IRAK-1 may be involved in the differentiation and maturation of DCs.
Previous studies (26, 27) demonstrated that when BMSCs-originated DCs were treated with LPS, IRAK-1 expression was significantly upregulated and NF-κB was upregulated, thus suggesting that LPS-stimulated maturation of DCs was induced via the TLRs/IL-1Rs pathway. Namely, LPS may bind with TLRs on the surface of DCs, induce the upregulation of IRAK-1, and thus promote the expression of NF-κB and initiation of the immune responses. The present study used RNAi technology to transfect DCs with IRAK-1 siRNA to inhibit the gene expression of IRAK-1. The results Figure 6 . Dendritic cells and naive T cells were co-cultured, and proliferation was determined using the MTS assay. When the proportion of DC to naive T cells was high, the LPS + IRAK-1 siRNA group exhibited weakened promoting effects on the proliferation of naive T cells. There was no difference between the LPS + mock and LPS + scrambled siRNA groups. IRAK-1, interleukin-1 receptor-associated kinase 1; LPS, lipopolysaccharide; siRNA, small interfering RNA. 
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demonstrated that the differentiation and maturation of DCs were inhibited; flow cytometry revealed that the expression levels of DC surface markers: CD80, MHC II and CD40, were significantly reduced. IL-10 is a pleiotropic cytokine, the primary function of which is to limit or terminate inflammatory responses. IL-10 is able to regulate the growth and differentiation of several types of cells, including B cells, natural killer cells, cytotoxic T cells, Th cells, monocytes and DCs (28) . IL-12 and TNF-α are well-recognized inflammatory factors, which promote inflammatory responses and activate immune cells. Previous studies have suggested that IL-10 has an important role in the occurrence and development of autoimmune diseases, including multiple sclerosis (29, 30) . IL-10 is able to reduce the expression of IL-12 and TNF-α in various cells, and can downregulate the functions of APCs, thereby regulating the functions of proinflammatory T cells (31) . In particular, IL-10 can limit the inappropriate amplification of Th17 cells (32) . A previous also demonstrated that IL-10 could inhibit the expression of IL-12 in DCs (33) .
The present study demonstrated that following RNAi to silence the expression of IRAK-1 in DCs, the DCs' abilities to release IL-12 and TNF-α were decreased, whereas the expression levels of IL-10 were increased, thus suggesting that the suppression of IRAK-1 could reduce inflammation. In order to further assess the functional alterations of DCs, DCs were co-cultured with naive CD4 + T cells. The results demonstrated that the promoting effects of DCs towards the proliferation of CD4 + T cells were significantly inhibited by IRAK-1 siRNA, this inhibition was associated with the ratio of DCs to co-cultured lymphocytes; the higher the ratio, the more obvious the inhibitory effects. These results suggested that IRAK-1 may serve key roles in the differentiation and maturation of DCs.
In conclusion, during LPS-mediated differentiation and maturation of DCs, IRAK-1 may serve key roles. Following the suppression of IRAK-1, the differentiation and maturation of DCs was inhibited in several ways; IRAK-1 RNAi reduced the expression of cell surface factors CD86, CD40 and MHC II; reduced mRNA expression of NF-κB p65; reduced the expression of proinflammatory cytokines IL-12 and TNF-α, and enhanced the expression of the anti-inflammatory cytokine IL-10. In addition, the promoting abilities of DCs towards the activation and proliferation of T cells were reduced. Following the completion of further studies regarding the mechanisms of IRAKs in innate immune processes, novel drugs and methods may be identified for the clinical treatment of autoimmune diseases, such as systemic lupus erythematosus and multiple sclerosis, thus advancing the diagnosis and treatment of human autoimmune diseases.
